Published in Pathol Oncol Res on June 08, 2011
Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS One (2011) 1.07
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. PLoS One (2012) 0.99
The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis. Diagn Pathol (2013) 0.86
Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol. BMJ Open (2014) 0.81
Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer. PLoS One (2014) 0.78
Expression of XPG protein in human normal and tumor tissues. Int J Clin Exp Pathol (2013) 0.77
Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China. Oncotarget (2016) 0.76
The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis. Medicine (Baltimore) (2016) 0.75
GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects. J Cancer (2016) 0.75
Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses. Sci Rep (2016) 0.75
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis. Oncotarget (2016) 0.75
Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. Radiology (2010) 1.51
Fracture of the penis: management and long-term results of surgical treatment. Experience in 300 cases. J Trauma (2008) 1.43
Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res (2010) 1.42
Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment. Target Oncol (2010) 1.21
Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med (2011) 1.02
[Genito-urinary malacoplakia. Report of 10 cases and review of the literature]. Ann Urol (Paris) (2002) 0.97
Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib. Invest New Drugs (2010) 0.95
Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy. Tumour Biol (2012) 0.94
[Emphysematous pyelonephritis. Epidemiological, clinical, biological, bacteriological, radiological, therapeutic and prognostic features. Retrospective study of 30 cases]. Tunis Med (2012) 0.91
Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail. Int J Oncol (2010) 0.89
Clinical presentation and outcome of bladder schistosoma-unrelated squamous cell carcinoma: report on 33 consecutive cases. Clin Genitourin Cancer (2007) 0.89
Estimation of intra-operator variability in perfusion parameter measurements using DCE-US. World J Radiol (2011) 0.87
The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer (2011) 0.87
Surgical complications in pediatric and adolescent renal transplantation. Saudi J Kidney Dis Transpl (2010) 0.85
Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry. J Biomed Biotechnol (2008) 0.85
Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients. Cancer Invest (2010) 0.85
Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2007) 0.84
Primary testicular non-Hodgkin lymphoma. a 10-year Tunisian single-institute experience. Tunis Med (2013) 0.84
NY-ESO-1 expression and immunogenicity in prostate cancer patients. Tunis Med (2011) 0.84
HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathol Oncol Res (2006) 0.83
[Imaging of renal hydatid cyst based on a series of 41 cases]. Prog Urol (2006) 0.83
Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumour Biol (2013) 0.83
Imaging of melanoma: usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment. Clin Cosmet Investig Dermatol (2011) 0.83
Prognostic factors of recurrence after vesicovaginal fistula repair. Int J Urol (2006) 0.82
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS One (2012) 0.82
[Place of endoscopic treatment of complicated ureteroceles in adults]. Prog Urol (2007) 0.82
Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.82
[Ureterocalicostomy: last resort in the treatment of certain forms of ureteropelvic junction stenosis. Report of 5 cases]. Prog Urol (2005) 0.82
Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biol (2014) 0.82
Islands inside an island: reproductive isolates on Jerba island. Am J Hum Biol (2006) 0.81
Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses. Tumour Biol (2013) 0.81
Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev (2009) 0.81
Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy. Ultrastruct Pathol (2012) 0.80
CD99 and HLA-II immunostaining in breast cancer tissue and their correlation with lymph node metastasis. Dis Markers (2013) 0.80
Vascular complications after pediatric kidney transplantation. Tunis Med (2011) 0.80
Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.80
Kidney trauma with underlying renal pathology: is conservative management sufficient? Saudi J Kidney Dis Transpl (2011) 0.80
[Reno-colo-pancreatic fistula: an exceptional complication of renal hydatic cyst]. Tunis Med (2008) 0.80
Factor VIII haplotypes frequencies in Tunisian hemophiliacs A. Diagn Pathol (2011) 0.79
The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol (2007) 0.79
Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors. Cancer Invest (2009) 0.79
In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves. Ultrasonics (2011) 0.78
A new case of signet ring cell carcinoma of the prostate. Clin Genitourin Cancer (2007) 0.78
A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer. Clin Chim Acta (2010) 0.78
Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bull Cancer (2011) 0.78
MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev (2011) 0.78
3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer. Med Oncol (2014) 0.78
Association analysis of LCE3C-LCE3B deletion in Tunisian psoriatic population. Arch Dermatol Res (2012) 0.78
Risk factors and consequences of delayed graft function. Saudi J Kidney Dis Transpl (2013) 0.77
[Primary psoas abscesses of the psoas muscle in children]. Tunis Med (2012) 0.77
Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis. Clin Chim Acta (2007) 0.77
The utility of alpha-methyl CoA racemase (P504S) expression as a marker of renal cell carcinomas. Tunis Med (2010) 0.77
Evaluation of urolithiasis in Crohn's disease in Tunisian patients. Tunis Med (2013) 0.77
Seminal vesicle abscess: report of a new case. Tunis Med (2009) 0.77
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer. Mol Biol Rep (2013) 0.77
Somatic mutation of MutYH in Tunisian patients with sporadic colorectal cancer. J Clin Lab Anal (2007) 0.77
Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy. Ultrastruct Pathol (2012) 0.76
Experimental and computational studies indicate specific binding of pVHL protein to Aurora-A kinase. J Phys Chem B (2010) 0.76
Biochemical genetic relationships among Tunisian hares (Lepus sp.), South African cape hares (L. capensis), and European brown hares (L. europaeus). Biochem Genet (2005) 0.76
Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study. Tumour Biol (2013) 0.76
Short- and long-term outcomes of kidney donors: a report from Tunisia. Saudi J Kidney Dis Transpl (2012) 0.76
Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genet Cytogenet (2008) 0.76
In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice. Int J Toxicol (2011) 0.76
Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment. Med Oncol (2014) 0.76
First genetic analysis in Tunisian familial adenomatous polyposis probands. Oncol Rep (2008) 0.76
Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population. Bull Cancer (2011) 0.76
The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients. Bull Cancer (2008) 0.75
Carcinome épidermoïde de l'urètre masculin révélé par une rupture spontanée de l'urètre. Can Urol Assoc J (2011) 0.75